Drug intelligence / Profile preview

DMT310 + hydrogen peroxide

Development stage
Unknown
Lead developer
Dermata Therapeutics
Modality
Small Molecules
Administration
Topical
01

Overview

DMT310 + hydrogen peroxide is a hypothetical or investigational combination therapy, where **DMT310** is a topical drug derived from the processed freshwater sponge *Spongilla lacustris* and hydrogen peroxide is a commonly used antiseptic/antimicrobial agent. DMT310 acts via both mechanical (microchannel formation, exfoliation, and spicule action) and chemical (antimicrobial, anti-inflammatory, and sebum-modulating properties) mechanisms to treat inflammatory skin diseases such as moderate-to-severe acne vulgaris and rosacea. It promotes exfoliation, boosts collagen formation, opens closed comedones and facilitates deeper penetration of active compounds. The hydrogen peroxide component, if part of the formulation, would further provide broad-spectrum antimicrobial activity, enhancing the clearance of pathogens and oxidative reduction of skin debris. DMT310 is being developed by Dermata Therapeutics primarily for dermatologic indications and is currently in late-stage clinical development for acne vulgaris[1][2][6][5]. **Note:** No publicly available evidence confirms the existence of a formal combination product of DMT310 with hydrogen peroxide, but both are recognized as having antimicrobial and anti-inflammatory topical effects.

Brand names
DMT310 + hydrogen peroxide
Other names
DMT310 + hydrogen peroxide
02

Targets

IL-17A (Interleukin-17A)IL17F (Interleukin 17F)

Beyond the preview

Go deeper on DMT310 + hydrogen peroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DMT310 + hydrogen peroxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call